•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

JSA, Rajani Singhania steer FIPB-free Japanese pharma buy after DIPP note

J Sagar Associates (JSA) advised the shareholders of Lilac Medicare on selling it off to Japan’s Tosoh Corporation and Singapore’s Tosoh Asia which were advised by Rajani Singhania & Partners.

JSA partner Sidharrth Shankar, senior associate Shantanu Jindel and associates Prakriti Jaiswal and Priyam Singh acted for Lilac.

Rajani partner Reena Grover acted for Tosoh.

This is a notable transaction in the pharma space, which did not require the approval of the Foreign Investment Promotion Board, after the Department of Industrial Policy and Promotion notified Press Note 2 of 2015, according to JSA’s press release.

The $7.5bn Tosoh is one of the largest chlor-alkali manufacturers in Asia, reported Business Standard.

Click to show 3 comments
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.